Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients

Eur Respir J. 2015 Jul;46(1):271-4. doi: 10.1183/09031936.00188114. Epub 2015 Apr 2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Retroviral Agents / therapeutic use
  • Child
  • Extensively Drug-Resistant Tuberculosis / complications
  • Extensively Drug-Resistant Tuberculosis / drug therapy
  • Female
  • Fluoroquinolones / therapeutic use
  • HIV Infections / complications*
  • HIV Infections / drug therapy*
  • Humans
  • Linezolid / administration & dosage*
  • Male
  • Middle Aged
  • Retrospective Studies
  • South Africa
  • Tuberculosis, Multidrug-Resistant / complications*
  • Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

  • Anti-Bacterial Agents
  • Anti-Retroviral Agents
  • Fluoroquinolones
  • Linezolid